Report for: Nicotine vaccines for smoking cessation

Title	Nicotine vaccines for smoking cessation
Published in	Cochrane database of systematic reviews, August 2012
DOI	10.1002/14651858.cd007072.pub2
Pubmed ID	22895958
Authors	Jamie Hartmann-Boyce, Kate Cahill, Dorothy Hatsukami, Jacques Cornuz
Abstract	By reducing the amount of nicotine that reaches the brain when a person smokes a cigarette, nicotine vaccines may help people to stop smoking or to prevent recent quitters from relapsing.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
United States	3	33%
Spain	1	11%
Malaysia	1	11%
Indonesia	1	11%
Australia	1	11%
Unknown	2	22%

Demographic breakdown

Type	Count	As %
Members of the public	8	89%
Scientists	1	11%

Mendeley readers

The data shown below were compiled from readership statistics for 171 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
Netherlands	1	<1%
Brazil	1	<1%
Unknown	169	99%

Demographic breakdown

Readers by professional status	Count	As %
Student > Master	34	20%
Researcher	20	12%
Student > Ph. D. Student	20	12%
Student > Bachelor	16	9%
Student > Doctoral Student	12	7%
Other	25	15%
Unknown	44	26%

Readers by discipline	Count	As %
Medicine and Dentistry	50	29%
Psychology	17	10%
Nursing and Health Professions	17	10%
Pharmacology, Toxicology and Pharmaceutical Science	7	4%
Agricultural and Biological Sciences	6	4%
Other	23	13%
Unknown	51	30%

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 February 2022.

All research outputs

#1,566,047

of 23,103,436 outputs

Outputs from Cochrane database of systematic reviews

#3,591

of 12,367 outputs

Outputs of similar age

#9,918

of 168,323 outputs

Outputs of similar age from Cochrane database of systematic reviews

#53

of 207 outputs

Altmetric has tracked 23,103,436 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,367 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.3. This one has gotten more attention than average, scoring higher than 70% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,323 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.

We're also able to compare this research output to 207 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.

Cochrane Database of Systematic Reviews

Nicotine vaccines for smoking cessation

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context